Healthcare

Glaukos

$84.91
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.06 (-0.08%) As of 3:42 PM UTC today

Why Robinhood?

You can buy or sell Glaukos and other stocks, options, and ETFs commission-free!

About GKOS

Glaukos Corporation, also called Glaukos, is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard Hill on July 14, 1998 and is headquartered in San Clemente, CA. The listed name for GKOS is Glaukos Corporation.

CEO
Thomas William Burns
Employees
600
Headquarters
San Clemente, California
Founded
1998
Market Cap
3.97B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
534.87K
High Today
$86.31
Low Today
$84.70
Open Price
$85.74
Volume
39.84K
52 Week High
$90.71
52 Week Low
$23.31

Collections

GKOS Earnings

-$0.76
-$0.51
-$0.25
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 25, After Hours

You May Also Like

GOVXW
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure